Hailing Lu Selected Research

Hailing Lu Research Topics

Disease

39	Neoplasms (Cancer) 01/2022 - 07/2006
17	Breast Neoplasms (Breast Cancer) 12/2019 - 07/2006
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 11/2013
8	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2011
5	Adenocarcinoma of Lung 01/2020 - 07/2018
5	Lung Neoplasms (Lung Cancer) 01/2020 - 11/2013
2	Synovial Sarcoma (Synovioma) 01/2022 - 10/2017
2	Lymphoma (Lymphomas) 01/2020 - 05/2003
2	Inflammation (Inflammations) 01/2020 - 05/2010
2	Testicular Neoplasms (Testicular Cancer) 10/2019 - 10/2017
2	Pathologic Processes 01/2018 - 12/2015
2	Carcinogenesis 09/2014 - 01/2013
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Myxoid Liposarcoma 01/2022
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Triple Negative Breast Neoplasms 12/2019
1	Pathologic Complete Response 01/2019
1	Necrosis 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Lymphatic Metastasis 12/2013

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
9	AntigensIBA 12/2019 - 10/2006
6	ErbB Receptors (EGF Receptor)IBA 01/2020 - 11/2013
5	VaccinesIBA 11/2020 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 07/2018 - 02/2007
5	AntibodiesIBA 05/2014 - 12/2004
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2018
4	AutoantibodiesIBA 05/2014 - 04/2008
3	Gefitinib (Iressa)FDA Link 01/2020 - 05/2016
3	Biological ProductsIBA 01/2018 - 01/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 12/2015
3	polysaccharide-KIBA 08/2013 - 01/2011
3	Trastuzumab (Herceptin)FDA Link 11/2011 - 10/2009
2	Toll-Like Receptor 4IBA 01/2022 - 01/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2020 - 01/2013
2	Ubiquitin-Specific ProteasesIBA 01/2020 - 10/2018
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 11/2018 - 12/2015
2	Cadherins (E-Cadherin)IBA 07/2018 - 12/2013
2	VTX-2337IBA 01/2018 - 01/2016
2	Imiquimod (Aldara)FDA LinkGeneric 07/2017 - 05/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2017 - 03/2011
2	Estrogen ReceptorsIBA 09/2014 - 10/2006
2	Toll-Like Receptor AgonistsIBA 01/2014 - 05/2010
2	Polysaccharides (Glycans)IBA 04/2012 - 01/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 04/2008 - 10/2006
1	atezolizumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	pembrolizumabIBA 01/2022
1	Recombinant ProteinsIBA 11/2020
1	EmulsionsIBA 01/2020
1	glucopyranosyl lipid-AIBA 01/2020
1	Complementary DNA (cDNA)IBA 12/2019
1	Pharmaceutical PreparationsIBA 11/2018
1	Deubiquitinating EnzymesIBA 10/2018
1	ELAV-Like Protein 2IBA 07/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	130-nm albumin-bound paclitaxelIBA 07/2017
1	Albumin-Bound Paclitaxel FDA Link 07/2017
1	sphingosine kinaseIBA 05/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	nedaplatinIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Toll-Like Receptor 8IBA 01/2016
1	Insulin Receptor Substrate ProteinsIBA 10/2014
1	Forkhead Box Protein M1IBA 09/2014
1	Hormones (Hormone)IBA 09/2014
1	Tamoxifen FDA LinkGeneric 09/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2014
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 09/2014
1	ChromatinIBA 09/2014
1	Immunoglobulin M (IgM)IBA 05/2014
1	Immunoglobulin G (IgG)IBA 05/2014
1	Cell Adhesion MoleculesIBA 12/2013
1	CateninsIBA 12/2013
1	OsteopontinIBA 12/2013
1	Caveolin 1IBA 11/2013
1	ParaffinIBA 11/2013
1	Aromatase InhibitorsIBA 08/2013
1	Diphosphonates (Bisphosphonates)IBA 08/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2013
1	Transferrin (beta 2 Transferrin)IBA 01/2013
1	artemisinin (artemisinine)IBA 01/2013
1	SurvivinIBA 01/2013
1	Epidermal Growth Factor (EGF)IBA 01/2013
1	beta CateninIBA 01/2013
1	Cyclin D1IBA 01/2013
1	Prednisolone (Predate)FDA LinkGeneric 08/2012
1	Cyclin B1IBA 08/2012
1	Carcinoembryonic AntigenIBA 08/2012
1	Messenger RNA (mRNA)IBA 04/2012

Therapy/Procedure

11	Therapeutics 01/2022 - 07/2006
7	Drug Therapy (Chemotherapy) 11/2018 - 11/2011
6	Immunotherapy 01/2020 - 07/2006
2	Injections 01/2022 - 01/2020
1	Time-to-Treatment 01/2016
1	Chemoprevention 08/2013
1	Castration 04/2012